SGEuropean Union officials are examining whether Singapore's Project Wolbachia, which uses genetically modified mosquitoes to reduce dengue transmission, could be adapted for use in Europe. The initiative, launched in Singapore in 2016, involves releasing male mosquitoes infected with Wolbachia bacteria, which prevents female mosquitoes from producing viable offspring. This has led to an 80-90% reduction in mosquito populations and a over 70% decrease in dengue risk. EU health officials, including Director-General Florika Fink-Hooijer, visited Singapore to assess the program's potential, noting challenges such as differences in mosquito species, environmental conditions, and regulatory frameworks. While the approach shows promise, experts emphasize that adaptation would require tailored strategies suited to Europe's unique ecological and social contexts.
Bias read (Center): The article presents a balanced overview of the scientific and logistical considerations surrounding the potential adoption of Project Wolbachia in Europe. It highlights both the successes of the Singapore model and the significant challenges of adapting it to European environments. There is no明显的倾向
